万维提示：
1、投稿方式：在线投稿。
2、刊内网址（202504期）：
https://www.keaipublishing.com/en/journals/intelligent-oncology/
3、投稿系统：
https://www2.cloud.editorialmanager.com/intonc/default2.aspx
4、刊内电话：023-68588817
5、刊内邮箱：EditorialOffice@intelligent-oncology.net
6、出刊日期：季刊，逢季末月出版。
7、官方微信公众号：智能肿瘤学（intelligentoncology）
2026年3月12日星期四
Guide for Authors
【官网信息】
Introduction
Types of paper
Full-length/ Research Article (Word limit: 7000)
A complete report on original research and/or clinical studies.
A structured abstract is required.
A clear structure is required, which should contain but not confined to the following sections:
Introduction
Material and methods
Results
Discussion
Conclusions
Authors' contribution (For details please visit the link.)
Ethic statement
COI
(acknowledgments/clarification)
Bibliography
Appendices (including multimedia components)
Review Article (Word limit: 9000)
A substantial overview presents a complete overview of the state of the art with a comprehensive bibliography, generally, also contains a table of contents. It should cover topics that have seen significant development or progress in recent years, with comprehensive depth and a balanced perspective. Review articles should NOT include unpublished material such as unpublished/original data, submitted manuscripts, or personal communication.
Editorial(Word limit: 1000)
Generally from the (guest) editor of the publication. Can be Foreword, Editorial, Guest Editorial, Preface, etc.
Short Communication (Word limit: 2000)
Short report or announcement of research, usually claiming certain results, which present original and significant material for rapid dissemination. Short Communications are expected to have a higher than average impact on the field rather than report on incremental research.
Guideline/Consensus (Word limit: 10000)(for clinical medicine only)
Guidelines: Documents that have been locally or internationally approved and contain general principles that may benefit others in their clinical practice or in writing their own guidelines.
Consensus: Evidence-based analyses of issues that integrate findings, ideas and/or conceptual frameworks from a variety of sources in a clear and balanced way.
Meeting Reports, News and Announcements (Word limit: 1500)
Meeting reports Summary of a relevant symposium, workshop, etc. Or, information about a conference (can be a description of the venture, but also a visit report of a scientist who has attended a conference).
Letter to the Editor (Word limit: 2,000)
Any items of interest to the wide audience of the publication. The items include a letter to the editor commenting on previously published articles or a reply to the letter. (The letter or reply needs a 'refers-to' DOI or PII number; or argumentative communication, like papers in a discussion, or commentaries, etc.(Subsequent discussion papers need a 'refers-to' DOI or PII number).
Perspective (Word limit: 3000)
An article presents a new and unique viewpoint on existing problems, fundamental concepts, or prevalent notions on a specific topic, propose and support a new hypothesis, or discuss the implications of a newly implemented innovation. Perspective pieces may focus on current advances and future directions on a topic and may include original data as well as personal opinion.
As a guideline, Perspective should not normally exceed 3,000 words. Perspectives allow up to 30 references; citations should be selective. Perspectives should include no more than 4 display items (figures, tables and/or boxes).
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
E-mail address
Full postal address
All necessary files have been uploaded:
Manuscript
Include keywords
All figures (include relevant captions)
All tables (including titles, description, footnotes)
Ensure all figure and table citations in the text match the files provided; Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations:
Manuscript has been 'spell checked' and 'grammar checked'
All references mentioned in the Reference List are cited in the text, and vice versa
Permission has been obtained for use of copyrighted material from other sources (including the Internet)
A competing interests statement is provided, even if the authors have no competing interests to declare
Journal policies detailed in this guide have been reviewed
For further information, visit our Support Center.
Before you begin
Ethics in Publishing
For information on Ethics in Publishing and Ethical guidelines for journal publication see https://www.elsevier.com/publishingethics and https://www.elsevier.com/ethicalguidelines.
Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect plagiarism issues including instances of overlapping and similar text in submitted manuscripts. Details can be found here. High similarity papers will be desk rejected.
Ethics approval and consent to participate
Manuscripts reporting studies involving human participants, human data or human tissue must:
• include a statement on ethics approval and consent (even where the need for approval was waived)
•include the name of the ethics committee that approved the study and the committee's reference number if appropriate.
All materials must adhere to high ethical and animal welfare standards. Any use of animals must be based on ethological knowledge and respect for species-specific requirements for health and well-being. A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval, must be included in the Methods section of the manuscript.
Consent for publication:
If your research or manuscript contains any individual person's data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.
Declaration of generative AI in scientific writing
Authors can declare the use of generative AI in scientific writing upon submission of the paper. The following guidance refers only to the writing process, and not to the use of AI tools to analyze and draw insights from data as part of the research process:
Generative AI and AI-assisted technologies should only be used in the writing process to improve the readability and language of the manuscript.
The technology must be applied with human oversight and control and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. Authors are ultimately responsible and accountable for the contents of the work.
Authors must not list or cite AI and AI-assisted technologies as an author or co-author on the manuscript since authorship implies responsibilities and tasks that can only be attributed to and performed by humans.
The use of generative AI and AI-assisted technologies in scientific writing can be declared by adding a statement at the end of the manuscript when the paper is first submitted. The statement will appear in the published work and should be placed in a new section before the references list. An example:
Title of new section: Declaration of generative AI and AI-assisted technologies in the writing process.
Statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.
The declaration does not apply to the use of basic tools, such as tools used to check grammar, spelling and references. If you have nothing to disclose, you do not need to add a statement.
We advise you to read our policy for authors on the use of generative AI and AI-assisted technologies for Elsevier.
Please note: to protect authors’ rights and the confidentiality of their research, this journal does not currently allow the use of Generative AI or AI-assisted technologies such as ChatGPT or similar services by reviewers or editors in the peer review and manuscript evaluation process. We are actively evaluating compliant AI tools and may revise this policy in the future.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
The author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the appropriate institutional committee(s). This statement should contain the date and reference number of the ethical approval(s) obtained. Authors should also include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
The journal will not accept manuscripts that contain data derived from unethically sourced organs or tissue, including from executed prisoners or prisoners of conscience, consistent with recommendations by Global Rights Compliance on Mitigating Human Rights Risks in Transplantation Medicine. For all studies that use human organs or tissues authors must provide sufficient evidence that they were procured in line with WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation. The source of the organs or tissues used in clinical research must be transparent and traceable. Authors of manuscripts describing organ transplantation must additionally declare within the manuscript:
that autonomous consent free from coercion was obtained from the donor(s) or their next of kin; and
that organs/tissues were not sourced from executed prisoners or prisoners of conscience.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Research Council's Guide for the Care and Use of Laboratory Animals and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Declaration of interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. This statement will be published within the article if accepted. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.To verify originality, your article automatically screened by the originality detection service CrossCheck.
......
更多详见：
https://www.keaipublishing.com/en/journals/intelligent-oncology/guide-for-authors/
